The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

  • See Evidence submitted by expert panel for details.

Variant: NM_000018.4(ACADVL):c.541dup (p.His181fs)

CA397723118

932736 (ClinVar)

Gene: ACADVL
Condition: very long chain acyl-CoA dehydrogenase deficiency
Inheritance Mode: Autosomal recessive inheritance
UUID: c7fb4c7f-e8f1-4b85-8190-55c2f183f3eb
Approved on: 2022-03-08
Published on: 2022-04-28

HGVS expressions

NM_000018.4:c.541dup
NM_000018.4(ACADVL):c.541dup (p.His181fs)
NC_000017.11:g.7221601dup
CM000679.2:g.7221601dup
NC_000017.10:g.7124920dup
CM000679.1:g.7124920dup
NC_000017.9:g.7065644dup
NG_007975.1:g.6768dup
NG_008391.2:g.3452dup
ENST00000356839.10:c.541dup
ENST00000322910.9:c.*496dup
ENST00000350303.9:c.475dup
ENST00000356839.9:c.541dup
ENST00000543245.6:c.610dup
ENST00000577191.5:n.618dup
ENST00000577433.5:n.749dup
ENST00000577857.5:n.357dup
ENST00000579286.5:n.722dup
ENST00000579886.2:c.379dup
ENST00000580365.1:n.272dup
ENST00000581378.5:n.259dup
ENST00000581562.5:n.525-351dup
ENST00000582166.1:n.522dup
ENST00000583312.5:c.541dup
ENST00000583760.1:n.323dup
NM_000018.3:c.541dup
NM_001033859.2:c.475dup
NM_001270447.1:c.610dup
NM_001270448.1:c.313dup
NM_001033859.3:c.475dup
NM_001270447.2:c.610dup
NM_001270448.2:c.313dup

Pathogenic

Met criteria codes 3
PP4_Moderate PM2_Supporting PVS1
Not Met criteria codes 1
PM3

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
ACADVL VCEP
The c.541dup (p.His181fs)variant in ACADVL is a frameshift variant predicted to cause a premature stop codon in biologically-relevant-exon 9/20 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1; PMIDs 9973285, 11590124). At least one patient with this variant displayed enzyme activity levels measured in lymphocytes of 6% of control values, which is highly specific for VLCAD deficiency (PP4_moderate, PMID 32463482). This variant is absent from gnomAD v2.1.1 (PM2_Supporting). In summary, this variant meets the criteria to be classified as pathogenic for autosomal recessive very long chain acyl-CoA dehydrogenase (VLCAD) deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen ACADVL Variant Curation Expert Panel: PVS1, PP4_moderate, PM2_supporting. VCEP specifications version2; 10/15/21.
Met criteria codes
PP4_Moderate
At least one patient with this variant displayed enzyme levels measured in lymphocytes of 6% of control values, which is highly specific for VLCAD deficiency (PP4_moderate, PMID 32463482).
PM2_Supporting
This variant is absent from gnomAD v2.1.1 (PM2_Supporting).
PVS1
The c.541dup (p.His181fs)variant in ACADVL is a frameshift variant predicted to cause a premature stop codon in biologically-relevant-exon 9/20 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1; PMIDs 9973285, 11590124).
Not Met criteria codes
PM3
This variant is reported in unconfirmed trans with another variant (c.1072A>G (p.Lys358Glu)) but this second variant is currently a VUS according to VCEP classification criteria and therefore no points are applied to PM3 for this evaluation.
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.